Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern China

被引:31
作者
Li, Xintao [1 ]
Guan, Bo [1 ]
Wang, Yanjun [1 ]
Tse, Gary [2 ,3 ]
Zou, Fuquan [3 ]
Khalid, Bin Waleed [3 ]
Xia, Yunlong [3 ]
Wu, Shouling [4 ]
Sun, Jianhui [1 ]
机构
[1] First Peoples Hosp Changzhou, Dept Cardiol, Changzhou 213000, Peoples R China
[2] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong 999077, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian 116011, Peoples R China
[4] Kailuan Gen Hosp, Dept Cardiol, Tangshan 063000, Peoples R China
关键词
CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN-A-I; HEART-DISEASE; HIGH-RISK; HDL CHOLESTEROL; SERUM-LIPIDS; NIACIN; IDEAL; MEN;
D O I
10.1038/s41598-019-50924-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies proposed reasonable doubts about the good prognosis of very high levels of high-density lipoprotein cholesterol (HDL-c). We aimed to investigate the association between HDL-c levels and all-cause mortality using data from an observational cohort study in northern China from 2006 to 2015. The study population was stratified into six groups by HDL-c levels in mg/dl (<40, 40-49, 50-59, 60-69, 70-79, >= 80). Cox hazards regression models were used to estimate the association between HDL-c levels and all-cause mortality. In total, 100,070 participants (aged 51.9 +/- 12.7 years) were included in the current analysis. During a mean follow-up of 8.76 years, 7,362 deaths were identified (mortality rate, 8.40 per 1000 person-years). There was a significant interaction effect between age and HDL-c levels (P for interaction < 0.001). Among individuals aged 65 and older, no significant association was found between HDL-c levels and total mortality. In contrast, HDL-c levels showed a U-shaped relationship with all-cause mortality in younger participants (<65 years old), and very high HDL-c levels (>= 80 mg/dl) were independently associated with increased total mortality risk compared with the reference level (60 to 69 mg/dl). These findings suggest that very high HDL-c levels may not represent a good prognosis, especially in younger individuals.
引用
收藏
页数:8
相关论文
共 37 条
[1]   Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting [J].
Angeloni, Emiliano ;
Paneni, Francesco ;
Landmesser, Ulf ;
Benedetto, Umberto ;
Melina, Giovanni ;
Luescher, Thomas Felix ;
Volpe, Massimo ;
Sinatra, Riccardo ;
Cosentino, Francesco .
EUROPEAN HEART JOURNAL, 2013, 34 (46) :3557-3562
[2]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[3]   High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among US Veterans [J].
Bowe, Benjamin ;
Xie, Yan ;
Xian, Hong ;
Balasubramanian, Sumitra ;
Zayed, Mohamed A. ;
Al-Aly, Ziyad .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (10) :1784-1793
[4]   Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. [J].
Cannon, Christopher P. ;
Shah, Sukrut ;
Dansky, Hayes M. ;
Davidson, Michael ;
Brinton, Eliot A. ;
Gotto, Antonio M., Jr. ;
Stepanavage, Michael ;
Liu, Sherry Xueyu ;
Gibbons, Patrice ;
Ashraf, Tanya B. ;
Zafarino, Jennifer ;
Mitchel, Yale ;
Barter, Philip .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25) :2406-2415
[5]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[6]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
KARDIOLOGIA POLSKA, 2016, 74 (11) :1234-1318
[7]   HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk [J].
Cooney, M. T. ;
Dudina, A. ;
De Bacquer, D. ;
Wilhelmsen, L. ;
Sans, S. ;
Menotti, A. ;
De Backer, G. ;
Jousilahti, P. ;
Keil, U. ;
Thomsen, T. ;
Whincup, P. ;
Graham, I. M. .
ATHEROSCLEROSIS, 2009, 206 (02) :611-616
[8]  
Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
[9]  
Ding D., 2014, SERUM LIPIDS APOLIPO, V2014, DOI [10.1155/2014/709756, DOI 10.1155/2014/709756]
[10]   Update on strategies to increase HDL quantity and function [J].
Duffy, Danielle ;
Rader, Daniel J. .
NATURE REVIEWS CARDIOLOGY, 2009, 6 (07) :455-463